 | • レポートコード：MRC2-11QY04605 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は鎌状赤血球のグローバル市場について調査・分析したレポートです。種類別（診断、治療）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別鎌状赤血球の競争状況、市場シェア ・世界の鎌状赤血球市場：種類別市場規模 2015年-2020年（診断、治療） ・世界の鎌状赤血球市場：種類別市場規模予測 2021年-2026年（診断、治療） ・世界の鎌状赤血球市場：用途別市場規模 2015年-2020年（病院、クリニック、外来外科センター） ・世界の鎌状赤血球市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来外科センター） ・北米の鎌状赤血球市場分析：米国、カナダ ・ヨーロッパの鎌状赤血球市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの鎌状赤血球市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の鎌状赤血球市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの鎌状赤血球市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Bristol-Myers Squibb、Takeda、Bluebird Bio、Global Blood Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.
The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.
Market Analysis and Insights: Global Sickle Cell Market
The global Sickle Cell market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sickle Cell Scope and Market Size
Sickle Cell market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Bristol-Myers Squibb
Takeda
Bluebird Bio
Global Blood Therapeutics
…
Market segment by Type, the product can be split into
Diagnosis
Treatment
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sickle Cell Revenue
1.4 Market by Type
1.4.1 Global Sickle Cell Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diagnosis
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Sickle Cell Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Market Perspective (2015-2026)
2.2 Global Sickle Cell Growth Trends by Regions
2.2.1 Sickle Cell Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sickle Cell Historic Market Share by Regions (2015-2020)
2.2.3 Sickle Cell Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sickle Cell Market Growth Strategy
2.3.6 Primary Interviews with Key Sickle Cell Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Players by Market Size
3.1.1 Global Top Sickle Cell Players by Revenue (2015-2020)
3.1.2 Global Sickle Cell Revenue Market Share by Players (2015-2020)
3.1.3 Global Sickle Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sickle Cell Market Concentration Ratio
3.2.1 Global Sickle Cell Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sickle Cell Revenue in 2019
3.3 Sickle Cell Key Players Head office and Area Served
3.4 Key Players Sickle Cell Product Solution and Service
3.5 Date of Enter into Sickle Cell Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sickle Cell Historic Market Size by Type (2015-2020)
4.2 Global Sickle Cell Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sickle Cell Market Size by Application (2015-2020)
5.2 Global Sickle Cell Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sickle Cell Market Size (2015-2020)
6.2 Sickle Cell Key Players in North America (2019-2020)
6.3 North America Sickle Cell Market Size by Type (2015-2020)
6.4 North America Sickle Cell Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sickle Cell Market Size (2015-2020)
7.2 Sickle Cell Key Players in Europe (2019-2020)
7.3 Europe Sickle Cell Market Size by Type (2015-2020)
7.4 Europe Sickle Cell Market Size by Application (2015-2020)
8 China
8.1 China Sickle Cell Market Size (2015-2020)
8.2 Sickle Cell Key Players in China (2019-2020)
8.3 China Sickle Cell Market Size by Type (2015-2020)
8.4 China Sickle Cell Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sickle Cell Market Size (2015-2020)
9.2 Sickle Cell Key Players in Japan (2019-2020)
9.3 Japan Sickle Cell Market Size by Type (2015-2020)
9.4 Japan Sickle Cell Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sickle Cell Market Size (2015-2020)
10.2 Sickle Cell Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sickle Cell Market Size by Type (2015-2020)
10.4 Southeast Asia Sickle Cell Market Size by Application (2015-2020)
11 India
11.1 India Sickle Cell Market Size (2015-2020)
11.2 Sickle Cell Key Players in India (2019-2020)
11.3 India Sickle Cell Market Size by Type (2015-2020)
11.4 India Sickle Cell Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sickle Cell Market Size (2015-2020)
12.2 Sickle Cell Key Players in Central & South America (2019-2020)
12.3 Central & South America Sickle Cell Market Size by Type (2015-2020)
12.4 Central & South America Sickle Cell Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Sickle Cell Introduction
13.1.4 Novartis Revenue in Sickle Cell Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Sickle Cell Introduction
13.2.4 Bristol-Myers Squibb Revenue in Sickle Cell Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview
13.3.3 Takeda Sickle Cell Introduction
13.3.4 Takeda Revenue in Sickle Cell Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Bluebird Bio
13.4.1 Bluebird Bio Company Details
13.4.2 Bluebird Bio Business Overview
13.4.3 Bluebird Bio Sickle Cell Introduction
13.4.4 Bluebird Bio Revenue in Sickle Cell Business (2015-2020)
13.4.5 Bluebird Bio Recent Development
13.5 Global Blood Therapeutics
13.5.1 Global Blood Therapeutics Company Details
13.5.2 Global Blood Therapeutics Business Overview
13.5.3 Global Blood Therapeutics Sickle Cell Introduction
13.5.4 Global Blood Therapeutics Revenue in Sickle Cell Business (2015-2020)
13.5.5 Global Blood Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Sickle Cell Key Market Segments
Table 2. Key Players Covered: Ranking by Sickle Cell Revenue
Table 3. Ranking of Global Top Sickle Cell Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sickle Cell Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diagnosis
Table 6. Key Players of Treatment
Table 7. Global Sickle Cell Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Sickle Cell Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Sickle Cell Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Sickle Cell Market Share by Regions (2015-2020)
Table 11. Global Sickle Cell Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Sickle Cell Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Sickle Cell Market Growth Strategy
Table 17. Main Points Interviewed from Key Sickle Cell Players
Table 18. Global Sickle Cell Revenue by Players (2015-2020) (Million US$)
Table 19. Global Sickle Cell Market Share by Players (2015-2020)
Table 20. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell as of 2019)
Table 21. Global Sickle Cell by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Sickle Cell Product Solution and Service
Table 24. Date of Enter into Sickle Cell Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 27. Global Sickle Cell Market Size Share by Type (2015-2020)
Table 28. Global Sickle Cell Revenue Market Share by Type (2021-2026)
Table 29. Global Sickle Cell Market Size Share by Application (2015-2020)
Table 30. Global Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 31. Global Sickle Cell Market Size Share by Application (2021-2026)
Table 32. North America Key Players Sickle Cell Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Sickle Cell Market Share (2019-2020)
Table 34. North America Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 35. North America Sickle Cell Market Share by Type (2015-2020)
Table 36. North America Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 37. North America Sickle Cell Market Share by Application (2015-2020)
Table 38. Europe Key Players Sickle Cell Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Sickle Cell Market Share (2019-2020)
Table 40. Europe Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Sickle Cell Market Share by Type (2015-2020)
Table 42. Europe Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Sickle Cell Market Share by Application (2015-2020)
Table 44. China Key Players Sickle Cell Revenue (2019-2020) (Million US$)
Table 45. China Key Players Sickle Cell Market Share (2019-2020)
Table 46. China Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 47. China Sickle Cell Market Share by Type (2015-2020)
Table 48. China Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 49. China Sickle Cell Market Share by Application (2015-2020)
Table 50. Japan Key Players Sickle Cell Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Sickle Cell Market Share (2019-2020)
Table 52. Japan Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Sickle Cell Market Share by Type (2015-2020)
Table 54. Japan Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Sickle Cell Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Sickle Cell Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Sickle Cell Market Share (2019-2020)
Table 58. Southeast Asia Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Sickle Cell Market Share by Type (2015-2020)
Table 60. Southeast Asia Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Sickle Cell Market Share by Application (2015-2020)
Table 62. India Key Players Sickle Cell Revenue (2019-2020) (Million US$)
Table 63. India Key Players Sickle Cell Market Share (2019-2020)
Table 64. India Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 65. India Sickle Cell Market Share by Type (2015-2020)
Table 66. India Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 67. India Sickle Cell Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Sickle Cell Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Sickle Cell Market Share (2019-2020)
Table 70. Central & South America Sickle Cell Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Sickle Cell Market Share by Type (2015-2020)
Table 72. Central & South America Sickle Cell Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Sickle Cell Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Sickle Cell Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Revenue in Sickle Cell Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Takeda Company Details
Table 85. Takeda Business Overview
Table 86. Takeda Product
Table 87. Takeda Revenue in Sickle Cell Business (2015-2020) (Million US$)
Table 88. Takeda Recent Development
Table 89. Bluebird Bio Company Details
Table 90. Bluebird Bio Business Overview
Table 91. Bluebird Bio Product
Table 92. Bluebird Bio Revenue in Sickle Cell Business (2015-2020) (Million US$)
Table 93. Bluebird Bio Recent Development
Table 94. Global Blood Therapeutics Company Details
Table 95. Global Blood Therapeutics Business Overview
Table 96. Global Blood Therapeutics Product
Table 97. Global Blood Therapeutics Revenue in Sickle Cell Business (2015-2020) (Million US$)
Table 98. Global Blood Therapeutics Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Market Share by Type: 2020 VS 2026
Figure 2. Diagnosis Features
Figure 3. Treatment Features
Figure 4. Global Sickle Cell Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Sickle Cell Report Years Considered
Figure 9. Global Sickle Cell Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Sickle Cell Market Share by Regions: 2020 VS 2026
Figure 11. Global Sickle Cell Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Sickle Cell Market Share by Players in 2019
Figure 14. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Sickle Cell Revenue in 2019
Figure 16. North America Sickle Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Sickle Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Sickle Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Sickle Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Sickle Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Sickle Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Sickle Cell Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
鎌状赤血球貧血治療薬の世界市場（～2026年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…- 血管閉塞症・鎌状赤血球症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-20…
- 鎌状赤血球症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sickle Cell Disease Drug Market The global Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sickle Cell Disease Drug Scope and Market Size Sickle Cell Diseas…
- 形質細胞新生物治療の世界市場（～2026年） Plasma cell neoplasms are diseases in which the body makes too many plasma cells. The plasma cells also make an antibody protein, called M protein, that is not needed by the body and does not help fight infection. These antibody proteins build up in the bone marrow and can cause the blood to thicken…
- 幹細胞臍帯血の世界市場（～2026年） Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered uniq…